News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Scientists identify potential new drug combination for children with incurable brain cancer
Combining two existing cancer drugs could offer promise for some children with an incurable childhood brain cancer, a new study suggests.
Taking a personalised approach to aggressive pancreatic cancers
Pancreatic cancer is highly aggressive and difficult to treat, but now our scientists are taking a more personalised approach. For Pancreatic Cancer Awareness Month, Gege Li looks at how our researchers are using artificial intelligence to improve treatment.
Liquid biopsies one step closer to entering the clinic to help guide breast cancer treatment
A simple blood test can identify specific genetic mutations in patients’ breast tumours to help guide their treatment and assess how likely patients are to relapse, a study shows.
Cancer researchers reveal direct block to DNA replication
For the first time, scientists have shown that a major protein acts as a direct block in multiple stages of DNA replication, improving our understanding of how cancer develops.
Professor Sir Michael Peckham, 1935 – 2021
Professor Sir Michael Peckham was Professor of Radiotherapy at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust from 1973 to 1985. In this obituary, former colleagues pay tribute to a brilliant scientist, artist and policymaker.
How decades of clinical trials have transformed breast cancer radiotherapy
After leading numerous practice-changing trials, Professor John Yarnold received a prestigious award at the 2021 ESTRO Congress. For Breast Cancer Awareness Month, Diana Cano looks back at the huge impact he has had in the field of breast cancer radiotherapy.
ICR research showcased in world-first exhibition exploring cutting-edge cancer research
A new world-first exhibition by the Science Museum Group titled Cancer Revolution: Science, innovation and hope features a series of pioneering research projects being carried out at The Institute of Cancer Research, London.
Targeted prostate cancer screening could benefit men with inherited cancer syndrome
Men who inherit an increased risk of cancer through ‘Lynch syndrome’ could benefit from regular PSA testing from age 40 to detect early signs of prostate cancer, researchers believe.
ICR ranked as one of world’s top research institutes for influence and commercial impact
The Institute of Cancer Research is one of the top-ranked higher education institutions in the world for academic influence and commercial impact, according to an international assessment.
ICR Discovery Club returns in-person, looks to the future of treating children with cancer
Members of the Discovery Club reunited at the Royal Society in London for an intimate evening with some of our leading childhood cancer scientists.
Researchers find immune system link with rare ovarian cancer that could guide future treatment
Immune-related genes are associated with the development of the rare cancer ovarian clear cell carcinoma (OCCC), new research has found.
-being-attacked-by-two-cytotoxic-t-cells-(red)-547x410.tmb-hbmobile.png?Culture=en&sfvrsn=8f59440b_2 "Immunotherapy - Oral squamous cancer cell (white) being attacked by two cytotoxic T cells (red) 547x410")
ESMO 2021: Immunotherapy combination could be alternative to ‘Extreme’ chemotherapy in some head and neck cancers
An immunotherapy combination could be better than standard ‘Extreme’ chemotherapy as first-line treatment for some patients with relapsed or metastatic head and neck cancer, or both, a major phase III trial suggests.
